News
2don MSN
Al Roker opens up to PEOPLE about maintaining a 100-lb. weight loss for more than two decades, which ultimately pulled the ...
2don MSN
The TODAY weatherman and 3rd Hour of TODAY co-host, 70, appears on the cover of People's Spring Health issue this month.
Kayla Girgen, RD, is a licensed dietitian who specializes in weight management and weight loss for patients after bariatric surgery. Water is the most abundant component in the body and is ...
May 12, 2025 – Turns out, two really is better than one – at least when it comes to weight loss drugs. In the first head-to-head trial of its kind, people with obesity who took tirzepatide ...
Lentil soup can help support weight loss if it’s part of a nutrient-dense and balanced diet. However, eating lentil soup alone may increase the risk of undereating or malnutrition. Lentils (Lens ...
After fans took notice of her new appearance, Trainor addressed her significant weight loss on Instagram, attributing her transformation to "huge lifestyle changes" such as using the weight-loss ...
Larger studies are needed to confirm the findings, which offer the latest evidence that the medicines can do much more than help people lose weight. Blockbuster weight loss drugs may help people ...
Some people with hyperparathyroidism may notice weight gain or weight loss. These changes may occur due to factors like underlying medical conditions or appetite changes. Hyperparathyroidism is ...
“We have learned over the past 20-odd years that in order to overcome plateau phenomenon in obesity, if you can add mechanisms that are completely different together, you can often get additional ...
Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment.
The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer. By Rebecca Robbins Novo Nordisk will replace its ...
The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight loss in a 72-week trial than Wegovy (semaglutide). Participants taking Zepbound lost 50 pounds (lb) on average ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results